These studies also confirmed the role of β-ARs in the modulation of angiogenesis and demonstrated that non-selective β-AR antagonists, but not β1-AR selective antagonists, promote apoptosis of cancer cells [40,41,42]. Here, ADRB2 is linked to cancer.